<code id='DAA8169F37'></code><style id='DAA8169F37'></style>
    • <acronym id='DAA8169F37'></acronym>
      <center id='DAA8169F37'><center id='DAA8169F37'><tfoot id='DAA8169F37'></tfoot></center><abbr id='DAA8169F37'><dir id='DAA8169F37'><tfoot id='DAA8169F37'></tfoot><noframes id='DAA8169F37'>

    • <optgroup id='DAA8169F37'><strike id='DAA8169F37'><sup id='DAA8169F37'></sup></strike><code id='DAA8169F37'></code></optgroup>
        1. <b id='DAA8169F37'><label id='DAA8169F37'><select id='DAA8169F37'><dt id='DAA8169F37'><span id='DAA8169F37'></span></dt></select></label></b><u id='DAA8169F37'></u>
          <i id='DAA8169F37'><strike id='DAA8169F37'><tt id='DAA8169F37'><pre id='DAA8169F37'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:focus    Page View:7
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In